• Markets
    • icon
  • Companies
PHX · ASX

PharmX Technologies Limited (ASX:PHX)

AU$0.04

 0.0 (0.0%)
ASX:Live
06/12/2023 10:47:31 AM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

PHX Overview

PHX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About PHX

Website

PharmX Technologies Limited

Telephone

61.2.9289.4699

Address

Level 3 120 Sussex Street Sydney, New South Wales (NSW) 2000

Description

PharmX Technologies Ltd. engages in the research and development of software solutions. It operates through the Health Services and eCommerce segment. The Health Services segment provides dispense and point of sale software applications, along with hardware and support services to Australian pharmacies. The eCommerce segment offers individuals and businesses the opportunity to pay their rent, utilities, local government fees, and commercial obligations via electronic methodologies. The company was founded in 1950 and is headquartered in Sydney, Australia.

PHX Price Chart

Key Stats

Market Cap

AU$25.74M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.02 - 0.04

Trade Value (12mth)

AU$1,446.00

1 week

-9.09%

1 month

7.34%

YTD

57.43%

1 year

47.59%

All time high

0.626335

Key Fundamentals

EPS 3 yr Growth

-460.000%

EBITDA Margin

23.20%

Operating Cashflow

$11m

Free Cash Flow Return

48.20%

ROIC

-3.90%

Interest Coverage

25.90

Quick Ratio

1.80

Other Data

Shares on Issue (Fully Dilluted)

597m

HALO Sector

Technology

Next Company Report Date

26-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

PHX Announcements

Latest Announcements

Date Announcements

22 November 23

Return of Capital - PHX

×

Return of Capital - PHX

21 November 23

Chair's Address to Shareholders

×

Chair's Address to Shareholders

21 November 23

Results of Meeting

×

Results of Meeting

20 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

17 October 23

Notification of cessation of securities - PHX

×

Notification of cessation of securities - PHX

16 October 23

Application for quotation of securities - PHX

×

Application for quotation of securities - PHX

15 November 23

Appointment of Chief Executive Officer

×

Appointment of Chief Executive Officer

05 December 23

Capital Return Confirmation

×

Capital Return Confirmation

04 October 23

Change of Company Name

×

Change of Company Name

PHX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.00 0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.00 0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 300.0 -80.0 -550.0 Lock Lock Lock
     PE X Lock Lock Lock Lock 22.5 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 0.01 0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.00 0.01 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.0 -6.2 -3.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock 4.1 15.6 49.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.04 0.04 0.04 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -69.6 -32.0 256.8 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 547 601 597 Lock Lock Lock
Basic m Lock Lock Lock Lock 543 597 597 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 12 5 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.5 -54.5 12.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 2 2 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 69.7 -30.9 -21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 19.8 30.0 21.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 80 70 79 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 3 2 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 856.4 -42.9 -18.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 25.5 32.0 23.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 352.4 -29.1 -53.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 10.4 16.3 6.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 1 0 -1 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 1 0 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 519.9 -76.9 -517.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 9.3 4.7 -17.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 3 3 11 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 4 4 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -6 -4 -4 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 3 3 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1,243.7 11.3 240.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.6 1.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 6 13 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 31 31 37 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -6 -5 -13 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 8 8 14 Lock Lock Lock
Equity $m Lock Lock Lock Lock 23 23 22 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 23 23 22 Lock Lock Lock
     Growth % Lock Lock Lock Lock 70.1 1.1 -4.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 3.5 0.8 -2.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.8 1.1 -4.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 5.3 3.7 1.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 4.7 -0.6 -3.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 13.8 14.1 48.2 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 22.4 343.0 25.9 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -2.1 -3.2 -9.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -26.9 -23.4 -57.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.6 1.7 1.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.6 1.7 1.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 62.2 67.1 56.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 49.5 64.2 89.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.9 2.0 2.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 277.7 89.3 226.4 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.9 1.5 0.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 26.6 39.5 17.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.4 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.4 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 6.2 0.5 -13.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 2.3 0.1 -2.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -47.5 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 3.5 0.8 -2.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.3 1.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 4.8 1.1 -4.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 4.8 1.1 -4.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 1.3 4.1 1.6 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 74.3 179.5 158.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 75.6 183.6 160.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 120.9 205.9 173.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -45.3 -22.3 -13.1 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

PHX Shortsell

Frequently Asked Questions

The current share price of PharmX Technologies Limited (PHX:ASX) is AU$0.04.
The 52-week high share price for PharmX Technologies Limited (PHX:ASX) is AU$0.04.
The 52-week low share price for PharmX Technologies Limited (PHX:ASX)? is AU$0.02.
PharmX Technologies Limited (PHX:ASX) does not pay a dividend.
The last dividend payment of PharmX Technologies Limited (PHX:ASX) is AU$1.01.
PharmX Technologies Limited (PHX:ASX) has a franking level of 0%.
PharmX Technologies Limited (PHX:ASX) is classified in the Technology.
The current P/E ratio for PharmX Technologies Limited (PHX:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.